Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2008 May 20;178(11):1466. doi: 10.1503/cmaj.080604

Correction

PMCID: PMC2374872

The lead author of a research paper1 in the April 8 issue has provided the following clarification. The initial Health Canada warnings about the use of antidepressants were directed toward people aged 18 years and younger; however, in June 2004, Health Canada expanded their warning to include all age groups. The implication of this omission for the study by Katz and colleagues is that the decrease in antidepressant use among young adults (19–24 years) is not a “spillover” effect but rather is a measure of the impact of the warning on young adults. The other events described in this study as “spillover effects” are accurately described.

REFERENCE

  • 1.Katz LY, Kozyrskyj AL, Prior HJ, et al. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ 2008;178:1005-1011. [DOI] [PMC free article] [PubMed]

Articles from CMAJ : Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES